Association of global sagittal spinal deformity with functional disability two years after total hip arthroplasty.

Disability Global sagittal deformity Spinopelvic alignment T1 pelvic angle, Total hip arthroplasty

Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
07 Jun 2021
Historique:
received: 17 03 2021
accepted: 26 05 2021
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 10 6 2021
Statut: epublish

Résumé

The relationship between spinopelvic alignment and functional disability after total hip arthroplasty (THA) has not been fully elucidated despite the growing recognition of its importance on patient-reported outcome measures. Therefore, our aim was to assess the effect of global sagittal spinal deformity on post-operative disability. This analysis was based on 208 cases of THA, with functional disability measured at a follow-up of 2 years. The Hip Disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR), ranging from a scale of 0 (complete joint disability) to 100 (perfect joint health), was used to divide eligible patients into two groups, namely with and without disability, using a score of 70 as the cut-off. The following factors were compared between the two groups using multivariate analysis: age, sex, body height, body mass index, spinopelvic parameters, and surgeon experience. To identify the cut-off value of the parameters for predicting disability (HOOS-JR < 70/100), we used the receiver-operating characteristic curve. The disability (30 hips) and control (178 hips) groups showed a significant difference in pre-operative body height (p = 0.020), T1 pelvic angle divided by pelvic incidence (T1PA/PI; p = 0.018), PI minus lumbar lordosis (p = 0.027), post-operative HOOS-JR (p = 0.010), patient satisfaction (p = 0.033), and the modified Harris Hip Score (p = 0.038). On multivariate analysis, the following factors were associated with persistent disability: T1PA/PI > 0.2 (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.19-4.14; p <  0.001) and height < 148 cm equivalent to legal standards as short stature (OR, 1.26; 95% CI, 1.09-1.48; p = 0.011). The cut-off value of pre-operative T1PA/PI was > 0.19, with a sensitivity of 95% and specificity of 85%. Post-operative satisfaction (p <  0.001), HOOS-JR (p = 0.023), and EuroQol 5-Dimension (p = 0.041) differed between the two groups when the pre-operative cut-off value was chosen as 0.2. A T1PA/PI > 0.2 was associated with greater disability after THA. Clinicians should be aware that patient-related factors, including global spinal deformities, particularly in patients with a short stature, can influence THA outcomes at 2 years postoperatively.

Sections du résumé

BACKGROUND BACKGROUND
The relationship between spinopelvic alignment and functional disability after total hip arthroplasty (THA) has not been fully elucidated despite the growing recognition of its importance on patient-reported outcome measures. Therefore, our aim was to assess the effect of global sagittal spinal deformity on post-operative disability.
METHODS METHODS
This analysis was based on 208 cases of THA, with functional disability measured at a follow-up of 2 years. The Hip Disability and Osteoarthritis Outcome Score-Joint Replacement (HOOS-JR), ranging from a scale of 0 (complete joint disability) to 100 (perfect joint health), was used to divide eligible patients into two groups, namely with and without disability, using a score of 70 as the cut-off. The following factors were compared between the two groups using multivariate analysis: age, sex, body height, body mass index, spinopelvic parameters, and surgeon experience. To identify the cut-off value of the parameters for predicting disability (HOOS-JR < 70/100), we used the receiver-operating characteristic curve.
RESULTS RESULTS
The disability (30 hips) and control (178 hips) groups showed a significant difference in pre-operative body height (p = 0.020), T1 pelvic angle divided by pelvic incidence (T1PA/PI; p = 0.018), PI minus lumbar lordosis (p = 0.027), post-operative HOOS-JR (p = 0.010), patient satisfaction (p = 0.033), and the modified Harris Hip Score (p = 0.038). On multivariate analysis, the following factors were associated with persistent disability: T1PA/PI > 0.2 (odds ratio [OR], 2.11; 95% confidence interval [CI], 1.19-4.14; p <  0.001) and height < 148 cm equivalent to legal standards as short stature (OR, 1.26; 95% CI, 1.09-1.48; p = 0.011). The cut-off value of pre-operative T1PA/PI was > 0.19, with a sensitivity of 95% and specificity of 85%. Post-operative satisfaction (p <  0.001), HOOS-JR (p = 0.023), and EuroQol 5-Dimension (p = 0.041) differed between the two groups when the pre-operative cut-off value was chosen as 0.2.
CONCLUSIONS CONCLUSIONS
A T1PA/PI > 0.2 was associated with greater disability after THA. Clinicians should be aware that patient-related factors, including global spinal deformities, particularly in patients with a short stature, can influence THA outcomes at 2 years postoperatively.

Identifiants

pubmed: 34098924
doi: 10.1186/s12891-021-04415-1
pii: 10.1186/s12891-021-04415-1
pmc: PMC8185940
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

523

Références

Clin Orthop Relat Res. 2016 Feb;474(2):321-9
pubmed: 26201420
J Arthroplasty. 2018 May;33(5):1606-1616
pubmed: 29233568
Bone Joint J. 2019 Jul;101-B(7):768-778
pubmed: 31256661
J Arthroplasty. 2020 Mar;35(3):801-804
pubmed: 31678016
Clin Orthop Relat Res. 2019 Jan;477(1):145-155
pubmed: 30179928
Eur Spine J. 1998;7(2):99-103
pubmed: 9629932
Spine J. 2012 May;12(5):363-9
pubmed: 22227176
J Arthroplasty. 2018 Nov;33(11):3416-3421
pubmed: 30057269
Acta Orthop. 2014 Sep;85(5):463-9
pubmed: 24954494
J Arthroplasty. 2021 Feb 10;:
pubmed: 33637383
J Orthop Sci. 2018 Nov;23(6):992-999
pubmed: 30122338
Spine (Phila Pa 1976). 2009 Aug 1;34(17):1828-33
pubmed: 19644334
J Bone Joint Surg Br. 2011 Jul;93(7):867-75
pubmed: 21705555
Clin Orthop Relat Res. 2018 Dec;476(12):2432-2441
pubmed: 30179951
J Arthroplasty. 2020 Sep;35(9):2458-2464
pubmed: 32416955
J Bone Joint Surg Br. 1986 May;68(3):382-6
pubmed: 3733801
Clin Orthop Relat Res. 2019 Feb;477(2):310-321
pubmed: 30300162
Eur Spine J. 2020 Sep;29(9):2354-2361
pubmed: 32488440
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Bone Miner Res. 1993 Sep;8(9):1137-48
pubmed: 8237484
J Arthroplasty. 2019 Sep;34(9):1999-2005
pubmed: 30979671
Clin Orthop Relat Res. 2017 Feb;475(2):336-350
pubmed: 27071391
J Bone Joint Surg Am. 2015 Dec 2;97(23):1913-20
pubmed: 26631991
Arch Orthop Trauma Surg. 2021 Feb 11;:
pubmed: 33570664
Acta Orthop. 2018 Jun;89(3):265-271
pubmed: 29508643
Diagn Interv Imaging. 2021 Feb;102(2):101-107
pubmed: 32532576
Gait Posture. 2017 Feb;52:293-300
pubmed: 28027530
J Arthroplasty. 2011 Feb;26(2):209-13
pubmed: 20462736
J Arthroplasty. 2020 Jan;35(1):160-165
pubmed: 31493962
J Arthroplasty. 2017 Jun;32(6):1910-1917
pubmed: 28153459
J Arthroplasty. 2019 Nov;34(11):2663-2668
pubmed: 31301908
Eur Spine J. 2002 Feb;11(1):80-7
pubmed: 11931071

Auteurs

Yoshinori Okamoto (Y)

Department of Orthopedic Surgery, Osaka Medical and Pharmaceutical University (Osaka Medical College), 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan. ort141@osaka-med.ac.jp.

Hitoshi Wakama (H)

Department of Orthopedic Surgery, Osaka Medical and Pharmaceutical University (Osaka Medical College), 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Tomohiro Okayoshi (T)

Department of Orthopedic Surgery, Osaka Medical and Pharmaceutical University (Osaka Medical College), 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Shuhei Otsuki (S)

Department of Orthopedic Surgery, Osaka Medical and Pharmaceutical University (Osaka Medical College), 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Masashi Neo (M)

Department of Orthopedic Surgery, Osaka Medical and Pharmaceutical University (Osaka Medical College), 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH